S
Sara E. Cosgrove
Researcher at Johns Hopkins University
Publications - 159
Citations - 23907
Sara E. Cosgrove is an academic researcher from Johns Hopkins University. The author has contributed to research in topics: Medicine & Antimicrobial stewardship. The author has an hindex of 48, co-authored 128 publications receiving 21413 citations. Previous affiliations of Sara E. Cosgrove include Harvard University & National Patient Safety Foundation.
Papers
More filters
Journal ArticleDOI
An intervention to decrease catheter-related bloodstream infections in the ICU
Peter J. Pronovost,Dale M. Needham,Sean M. Berenholtz,David J. Sinopoli,Haitao Chu,Sara E. Cosgrove,Bryan Sexton,Robert C. Hyzy,Robert J. Welsh,Gary Roth,Joseph Bander,John P. Kepros,Christine A. Goeschel +12 more
TL;DR: An evidence-based intervention resulted in a large and sustained reduction (up to 66%) in rates of catheter-related bloodstream infection that was maintained throughout the 18-month study period.
Journal ArticleDOI
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
Catherine Liu,Arnold S. Bayer,Sara E. Cosgrove,Robert S. Daum,Scott K. Fridkin,Rachel J. Gorwitz,Sheldon L. Kaplan,Adolf W. Karchmer,Donald P. Levine,Barbara E. Murray,Michael J. Rybak,Henry F. Chambers +11 more
TL;DR: These guidelines discuss the management of a variety of clinical syndromes associated with MRSA disease, including skin and soft tissue infections (SSTI), bacteremia and endocarditis, pneumonia, bone and joint infections, and central nervous system infections.
Journal ArticleDOI
Comparison of mortality associated with methicillin-resistant and methicillin-susceptible staphylococcus aureus bacteremia: A meta-analysis
Sara E. Cosgrove,George Sakoulas,Eli N. Perencevich,Mitchell J. Schwaber,Adolf W. Karchmer,Yehuda Carmeli,Yehuda Carmeli +6 more
TL;DR: A meta-analysis was performed to summarize the impact of methicillin-resistance on mortality in Staphylococcus aureus bacteremia and explored the reasons for heterogeneity by means of subgroup analyses.
Journal ArticleDOI
Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America
Tamar F. Barlam,Tamar F. Barlam,Sara E. Cosgrove,Lilian M. Abbo,Conan MacDougall,Audrey N. Schuetz,Edward Septimus,Arjun Srinivasan,Timothy H. Dellit,Yngve Falck-Ytter,Neil O. Fishman,Cindy W. Hamilton,Timothy C. Jenkins,Pamela A. Lipsett,Preeti N. Malani,Larissa S May,Gregory J. Moran,Melinda M. Neuhauser,Jason G. Newland,Christopher A. Ohl,Matthew H. Samore,Susan K. Seo,Kavita K. Trivedi +22 more
TL;DR: These recommendations address the best approaches for antibiotic stewardship programs to influence the optimal use of antibiotics.
Journal ArticleDOI
Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused by Staphylococcus aureus
Vance G. Fowler,Helen W. Boucher,G. Ralph Corey,Elias Abrutyn,Adolf W. Karchmer,Mark E. Rupp,Donald P. Levine,Henry F. Chambers,Francis P. Tally,Gloria Vigliani,Christopher H. Cabell,Arthur Stanley Link,Ignace DeMeyer,Scott G. Filler,Marcus J. Zervos,Paul P. Cook,Jeffrey Parsonnet,Jack M. Bernstein,Connie S. Price,Graeme N. Forrest,Gerd Fätkenheuer,Marcelo Gareca,Susan J. Rehm,Hans Reinhardt Brodt,Alan D. Tice,Sara E. Cosgrove +25 more
TL;DR: Daptomycin (6 mg per kilogram daily) is not inferior to standard therapy for S. aureus bacteremia and right-sided endocarditis and met prespecified criteria for the noninferiority of daptomecin.